Case Report: Precision Oncology Tumor Board
Exploiting homologous recombination repair alterations in metastatic castrate-resistant prostate cancer: a case report and literature review
Precision Cancer Medicine
2020;
3:
10
(15 March 2020)
Case Report: Precision Oncology Tumor Board
Utilizing genomic profiling in a patient with a thoracic malignancy of uncertain primary: case report
Precision Cancer Medicine
2020;
3:
9
(15 March 2020)
Case Report: Precision Oncology Tumor Board
Targeting EGFR mutations needs to be more precise with co-mutations
Precision Cancer Medicine
2020;
3:
8
(15 March 2020)
Review Article
Non-small cell lung cancer PDL1 >50%—should we go single or combo?
Precision Cancer Medicine
2020;
3:
7
(15 March 2020)
Review Article
Annotating the next generation sequencing report
Precision Cancer Medicine
2020;
3:
6
(15 March 2020)
Review Article
Non-small cell lung cancer targetable mutations: present and future
Precision Cancer Medicine
2020;
3:
5
(15 March 2020)
Review Article
Circulating tumor cells: moving forward into clinical applications
Precision Cancer Medicine
2020;
3:
4
(15 March 2020)
Original Article
Significance of alectinib in anaplastic lymphoma kinase-tyrosine kinase inhibitors for anaplastic lymphoma kinase-positive patients with non–small cell lung cancer
Precision Cancer Medicine
2020;
3:
3
(15 March 2020)
Editorial
Sharing data: a requirement for expanding precision oncology
Precision Cancer Medicine
2020;
3:
2
(15 March 2020)
Editorial
The current and future revolution in lung cancer screening and management
Precision Cancer Medicine
2020;
3:
1
(15 March 2020)